Jun 2026 (Q2 FY26) — Aug 6, 2026
The Joint Corp. Q2 FY26 — Re-franchising Nears Completion, Driving Profitability and Patient Retention
Read the full callJOINT (JYNT) earnings
- Jun 2026
- Jun 2026 (Q2 FY26)
- Dec 2025
JOINT earnings: last reported Thu, 6 Aug 2026, for the quarter ended Jun 2026.
Reported
The figures, each with its period
Each figure keeps its basis and period; nothing is filled in.
| Metric | Value | Change | Basis | Period | Note |
|---|---|---|---|---|---|
| Revenue | 15.2 | +14.4% YoY | Quarterly, as filed | Quarter to Jun 2026 | Revenue from operations as filed. |
| Operating margin | -2.4 | +6.2 pts YoY | Operating profit / revenue | Quarter to Jun 2026 | For the quarter; a change is in percentage points. |
| Net profit | Quarterly, as filed | Quarter to Jun 2026 | Not in the filed figures for the quarter to jun 2026. No older figure is substituted. |
Price
$7.27 +3.41% · +$0.24
Performance −11.7% 1Y
1Y: $8.23 on 17 Oct 2025 → $7.27. High $10.53 (15 Jan 2026), low $6.9 (14 Oct 2026).
- Previous close
- $7.03
- 52-week range
- $6.9 – $10.53
- One year
- −14.77%
Overview
- Symbol
- JYNT
- Sector
- Health Care
- Exchange
- US
- Currency
- USD
Call summaries
Every analysed call
JOINT earnings calls (JYNT)
Financials
What the filings say
| Line item | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 30 | 15 | 13 | 13 | 13 | 15 | 15 | 15 |
| Operating profit | -0 | 1 | -1 | -1 | 0 | 1 | 1 | -0 |
| Operating margin | −1.6% | 5.5% | −5.2% | −8.6% | 1.2% | 4.9% | 5.9% | −2.4% |
| Profit before tax | -0 | 1 | -0 | -1 | 0 | 1 | 1 | -0 |
| Tax rate | −1.3% | −2.2% | −2.7% | −1.2% | 3.4% | 0.4% | 1.0% | −3.8% |
| Net profit | -3 | — | — | — | — | — | — | — |
| EPS ($ per share) | -0.21 | 0 | 0.06 | 0.01 | 0.06 | 0.07 | 0.09 | 0.05 |
| Line item | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Equity capital | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reserves | -37 | -34 | -20 | -13 | -12 | -22 | -28 | -25 |
| Total liabilities | 23 | 38 | 45 | 57 | 61 | 62 | 62 | 46 |
| Fixed assets | 4 | 7 | 1 | 14 | 17 | 4 | 3 | 3 |
| Total assets | 23 | 44 | 66 | 87 | 93 | 87 | 83 | 61 |
| Line item | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | 5 | 8 | 11 | 14 | 8 | 15 | 9 | 2 |
| Cash from investing | -1 | -7 | -5 | -13 | -18 | -6 | -1 | 6 |
| Cash from financing | 0 | -1 | 6 | -2 | 0 | 0 | -2 | -10 |
| Net cash flow | 5 | -0 | 12 | -1 | -9 | 9 | 7 | -2 |
| Capital expenditure | -1 | -3 | -3 | -7 | -6 | -5 | -1 | -2 |
| Free cash flow | 4 | 4 | 8 | 7 | 2 | 10 | 8 | 0 |
Insider filings
23 filings between Nov 21, 2025 and Jun 10, 2026.
Open market
decisions to buy or sellPurchases
$1.98M
15 purchases by 1 insider
Sales
None
No insider sold shares.
Compensation
not trading decisions- 7
- Award — granted as compensation
- 1
- Tax withheld — shares kept back by the company to cover tax
Who traded
open market only| Insider | Bought | Sold | Last filing |
|---|---|---|---|
| JOBSON CHARLES E | $1.98M | — | May 13, 2026 |
Latest filings (36)
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| Jun 10, 2026 | Bowman Scott Justin Chief Financial Officer | Tax withheld | 1,392 | $11.7K |
| May 20, 2026 | Pant Milind Director | Award | 5,714 | $0 |
| May 20, 2026 | Karrmann Sandra R Director | Award | 5,714 | $0 |
| May 20, 2026 | Grandpre Christopher M Director | Award | 5,714 | $0 |
| May 20, 2026 | DaVella Ronald V Director | Award | 5,714 | $0 |
| May 20, 2026 | Rubel Matthew E Director | Award | 5,714 | $0 |
| May 13, 2026 | JOBSON CHARLES E 10% owner | Purchase | 20,375 | $174.6K |
| May 12, 2026 | JOBSON CHARLES E 10% owner | Purchase | 127,676 | $1.09M |
| Apr 21, 2026 | JOBSON CHARLES E 10% owner | Purchase | 509 | $4.4K |
| Mar 9, 2026 | Bowman Scott Justin Chief Financial Officer | Award | 28,301 | $0 |
| Mar 9, 2026 | Razdan Sanjiv Kumar See Remarks | Award | 73,484 | $0 |
| Feb 12, 2026 | JOBSON CHARLES E 10% owner | Purchase | 15,397 | $130.9K |
| Feb 11, 2026 | JOBSON CHARLES E 10% owner | Purchase | 448 | $3.9K |
| Jan 26, 2026 | JOBSON CHARLES E 10% owner | Purchase | 725 | $7.3K |
| Jan 23, 2026 | JOBSON CHARLES E 10% owner | Purchase | 16,753 | $167.5K |
| Jan 6, 2026 | JOBSON CHARLES E 10% owner | Purchase | 5,240 | $46.6K |
| Jan 2, 2026 | JOBSON CHARLES E 10% owner | Purchase | 1,393 | $12.1K |
| Dec 31, 2025 | JOBSON CHARLES E 10% owner | Purchase | 11 | $96 |
| Dec 5, 2025 | JOBSON CHARLES E 10% owner | Purchase | 10,000 | $84.1K |
| Dec 1, 2025 | JOBSON CHARLES E 10% owner | Purchase | 13,000 | $109.3K |
| Nov 25, 2025 | JOBSON CHARLES E 10% owner | Purchase | 2,081 | $17.5K |
| Nov 24, 2025 | JOBSON CHARLES E 10% owner | Purchase | 4,680 | $39.1K |
| Nov 21, 2025 | JOBSON CHARLES E 10% owner | Purchase | 10,000 | $85.0K |
| Aug 20, 2025 | Grandpre Christopher M Director | Purchase | 10,000 | $104.1K |
| Aug 18, 2025 | Grandpre Christopher M Director | Purchase | 10,000 | $107.0K |
| Aug 15, 2025 | Grandpre Christopher M Director | Purchase | 14,388 | $156.5K |
| Jun 10, 2025 | Bowman Scott Justin Chief Financial Officer | Award | 19,984 | $0 |
| Jun 3, 2025 | Karrmann Sandra R Director | Award | 4,849 | $0 |
| May 21, 2025 | Grandpre Christopher M Director | Award | 4,995 | $0 |
| May 21, 2025 | Decker Suzanne M Director | Award | 4,995 | $0 |
| May 21, 2025 | Rubel Matthew E Director | Award | 4,995 | $0 |
| May 21, 2025 | Hong Abe Director | Award | 4,995 | $0 |
| May 21, 2025 | DaVella Ronald V Director | Award | 4,995 | $0 |
| Mar 10, 2025 | Razdan Sanjiv Kumar See Remarks | Award | 50,973 | $0 |
| Mar 10, 2025 | Singleton Jake Chief Financial Officer | Award | 15,936 | $0 |
| Oct 14, 2024 | Razdan Sanjiv Kumar See Remarks | Award | 38,059 | $0 |
Source: SEC Form 4 filings. Form 4 reports transactions, not the cap table — absence of filings says nothing about how much an insider owns, and a quiet window is not a signal.
Your own record
Start an Inve Case for JOINT Corp
Free account. Everything above stays public.
Write why you follow JOINT Corp and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.
Keep reading